Why Vistagen Therapeutics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Lisa Levin
Shares of Vistagen Therapeutics, Inc. (NASDAQ:VTGN) rose by 12.6% in pre-market trading after Citadel Advisors LLC reported a 5.6% stake in the company. Other notable gainers include SciSparc Ltd. (NASDAQ:SPRC), WiSA Technologies, Inc. (NASDAQ:WISA), and Athersys, Inc. (NASDAQ:ATHX). On the other hand, Nuvve Holding Corp. (NASDAQ:NVVE), NetScout Systems, Inc. (NASDAQ:NTCT), and Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) were among the losers.
October 17, 2023 | 12:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Athersys, Inc. shares gained 51.5% after extending near-term liquidity with proceeds from warrant inducement and a global ARDS license with Healios to explore strategic alternatives.
The gain in Athersys, Inc.'s share price is likely due to the company extending near-term liquidity with proceeds from warrant inducement and a global ARDS license with Healios to explore strategic alternatives, which could be seen as a positive development.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
SciSparc Ltd. shares surged 79.5% after regaining compliance with the Nasdaq Minimum Bid Price Notification.
The surge in SciSparc Ltd.'s share price is likely due to the company regaining compliance with the Nasdaq Minimum Bid Price Notification, which could be seen as a positive development.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Vistagen Therapeutics shares rose by 12.6% after Citadel Advisors LLC reported a 5.6% stake.
The increase in Vistagen Therapeutics' share price is likely due to Citadel Advisors LLC reporting a 5.6% stake in the company, which could be seen as a vote of confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
WiSA Technologies shares rose 76.4% after announcing the pricing of a $4.8 million public offering of Series B convertible redeemable preferred stock and warrants.
The rise in WiSA Technologies' share price is likely due to the company announcing the pricing of a $4.8 million public offering of Series B convertible redeemable preferred stock and warrants, which could be seen as a positive development.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
NetScout Systems, Inc. shares fell 23% after the company reported weak preliminary results for the second quarter and lowered its FY24 guidance.
The fall in NetScout Systems, Inc.'s share price is likely due to the company reporting weak preliminary results for the second quarter and lowering its FY24 guidance, which could be seen as a negative development.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Nuvve Holding Corp. shares dipped 33.5% after gaining over 9% on Monday.
The dip in Nuvve Holding Corp.'s share price is likely due to market fluctuations and profit-taking after the stock gained over 9% on Monday.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Processa Pharmaceuticals, Inc. shares fell 18.6% after jumping 16% on Monday.
The fall in Processa Pharmaceuticals, Inc.'s share price is likely due to market fluctuations and profit-taking after the stock jumped 16% on Monday.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100